Entrada Therapeutics (TRDA)'s 30-day implied volatility (IV30) was 98.6% at the close on November 12, 2026, up from 98.2% the day before, against a 52-week range of 48.7% to 110.1%. Its 20-day historical volatility was 118.7%.
Data as of November 12, 2026.